日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Serum fibroblast growth factor 21 is a novel biomarker of cachexia in chronic liver disease

血清成纤维细胞生长因子21是慢性肝病恶病质的一种新型生物标志物。

Tanaka, Takatsugu; Suda, Goki; Ohara, Masatsugu; Maehara, Osamu; Yoda, Tomoka; Fu, Qingjie; Yang, Zijian; Yasuura, Naohiro; Meno, Akimitsu; Sasaki, Takashi; Kohya, Risako; Kitagataya, Takashi; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Ohnishi, Shunsuke; Sakamoto, Naoya

Serum FGF21 as a predictor of response to atezolizumab and bevacizumab in HCC.

血清 FGF21 作为预测 HCC 对阿特珠单抗和贝伐珠单抗反应的指标

Kohya Risako, Suda Goki, Ohara Masatsugu, Hosoda Shunichi, Sho Takuya, Chuma Makoto, Komori Atsumasa, Kugiyama Yuki, Yasui Yutaka, Tsuchiya Kaoru, Kurosaki Masayuki, Tani Joji, Kaneko Shun, Nakagawa Mina, Asahina Yasuhiro, Maekawa Shinya, Enomoto Nobuyuki, Yamamoto Yoshiya, Baba Masaru, Yamada Ren, Sasaki Takashi, Yoda Tomoka, Yoshida Sonoe, Fu Qingjie, Yang Zijian, Maehara Osamu, Ohnishi Shunsuke, Tokuchi Yoshimasa, Kitagataya Takashi, Kawagishi Naoki, Nakai Masato, Natsuizaka Mitsuteru, Ogawa Koji, Sakamoto Naoya

Advances of Nanozyme-Driven Multimodal Sensing Strategies in Point-of-Care Testing

纳米酶驱动的多模态传感策略在即时检测中的应用进展

Chang, Ziyi; Fu, Qingjie; Wang, Mengke; Duan, Demin

Simplified monitoring of sofosbuvir/velpatasvir in Japanese patients with chronic hepatitis C based on a retrospective analysis of a prospective multicenter cohort

基于对前瞻性多中心队列的回顾性分析,简化日本慢性丙型肝炎患者索非布韦/维帕他韦的监测

Suda, Goki; Baba, Masaru; Yamamoto, Yoshiya; Yoshida, Sonoe; Muranaka, Tetsuhito; Meguro, Takashi; Terashita, Katsumi; Ito, Jun; Kobayashi, Tomoe; Izumi, Takaaki; Takagi, Tomofumi; Hosoda, Shunichi; Yamada, Ren; Fu, Qingjie; Yang, Zijian; Yokoyama, Daisuke; Tanaka, Takatsugu; Meno, Akimitsu; Yasuura, Naohiro; Kitagataya, Takashi; Ohara, Masatsugu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Ogawa, Koji; Sakamoto, Naoya

Coexistence of muscle atrophy and high subcutaneous adipose tissue radiodensity predicts poor prognosis in hepatocellular carcinoma

肌肉萎缩和皮下脂肪组织放射密度增高同时存在预示着肝细胞癌预后不良。

Ohara, Masatsugu; Suda, Goki; Kohya, Risako; Sasaki, Takashi; Yoda, Tomoka; Yoshida, Sonoe; Fu, Qingjie; Yang, Zijian; Hosoda, Shunichi; Maehara, Osamu; Ohnishi, Shunsuke; Tokuchi, Yoshimasa; Kitagataya, Takashi; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Ogawa, Koji; Sakamoto, Naoya

Potential Correlation between Changes in Serum FGF21 Levels and Lenvatinib-Induced Appetite Loss in Patients with Unresectable Hepatocellular Carcinoma.

血清 FGF21 水平变化与 Lenvatinib 诱导的不可切除肝细胞癌患者食欲丧失之间可能存在相关性

Kohya Risako, Suda Goki, Ohara Masatsugu, Sasaki Takashi, Yoda Tomoka, Sakurai Naofumi, Yoshida Sonoe, Fu Qingjie, Yang Zijian, Hosoda Shunichi, Maehara Osamu, Ohnishi Shunsuke, Tokuchi Yoshimasa, Kitagataya Takashi, Suzuki Kazuharu, Kawagishi Naoki, Nakai Masato, Sho Takuya, Natsuizaka Mitsuteru, Ogawa Koji, Sakamoto Naoya

Serum Angiopoietin-2 Predicts the Occurrence and Recurrence of Hepatocellular Carcinoma after Direct-Acting Antiviral Therapy for Hepatitis C

血清血管生成素-2可预测丙型肝炎直接抗病毒治疗后肝细胞癌的发生和复发。

Kawagishi, Naoki; Suda, Goki; Yamamoto, Yoshiya; Baba, Masaru; Furuya, Ken; Maehara, Osamu; Ohnishi, Shunsuke; Yoshida, Sonoe; Fu, Qingjie; Yang, Zijian; Hosoda, Shunichi; Tokuchi, Yoshimasa; Kitagataya, Takashi; Ohara, Masatsugu; Suzuki, Kazuharu; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Ogawa, Koji; Sakamoto, Naoya

Small-molecule inhibitor cocktail promotes the proliferation of pre-existing liver progenitor cells

小分子抑制剂混合物促进已存在的肝脏祖细胞增殖

Fu, Qingjie; Ohnishi, Shunsuke; Suda, Goki; Sakamoto, Naoya

Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150

阿特珠单抗和贝伐珠单抗治疗不符合 IMbrave150 研究入组标准的不可切除肝细胞癌患者的疗效及对肝功能储备的影响

Sho, Takuya; Suda, Goki; Yamamoto, Yoshiya; Furuya, Ken; Baba, Masaru; Ogawa, Koji; Kubo, Akinori; Tokuchi, Yoshimasa; Fu, Qingjie; Yang, Zijian; Kimura, Megumi; Kitagataya, Takashi; Maehara, Osamu; Ohnishi, Shunsuke; Nakamura, Akihisa; Yamada, Ren; Ohara, Masatsugu; Kawagishi, Naoki; Natsuizaka, Mitsuteru; Nakai, Masato; Suzuki, Kazuharu; Izumi, Takaaki; Meguro, Takashi; Terashita, Katsumi; Takagi, Tomofumi; Ito, Jun; Kobayashi, Tomoe; Miyagishima, Takuto; Sakamoto, Naoya

Changes in Serum Growth Factors during Lenvatinib Predict the Post Progressive Survival in Patients with Unresectable Hepatocellular Carcinoma.

乐伐替尼治疗期间血清生长因子的变化可预测不可切除肝细胞癌患者的进展后生存期

Yang Zijian, Suda Goki, Maehara Osamu, Ohara Masatsugu, Yoshida Sonoe, Hosoda Shunichi, Kimura Megumi, Kubo Akinori, Tokuchi Yoshimasa, Fu Qingjie, Yamada Ren, Kitagataya Takashi, Suzuki Kazuharu, Kawagishi Naoki, Nakai Masato, Sho Takuya, Natsuizaka Mitsuteru, Morikawa Kenichi, Ogawa Koji, Ohnishi Shunsuke, Sakamoto Naoya